PRESS RELEASE published on 02/29/2024 at 13:38, 8 months 23 days ago MEDICLIN presents preliminary figures for the 2023 financial year MEDICLIN presents preliminary figures for the 2023 financial year, showing 3.6% sales growth and EUR 12.7 million operating result, impacted by a one-off effect. Capacity utilization above 80% in all quarters Sales Growth Financial Year Operating Result MEDICLIN Capacity Utilization
BRIEF published on 02/29/2024 at 13:38, 8 months 23 days ago MEDICLIN announces preliminary figures for fiscal year 2023 Healthcare Sector Sales Growth Financial Year MEDICLIN Results 2023
PRESS RELEASE published on 02/23/2024 at 15:04, 9 months ago MEDICLIN: Contract for the sale of the MEDICLIN Herzzentrum Coswig has been signed MEDICLIN signs contract for sale of MEDICLIN Herzzentrum Coswig to Johannesstift Diakonie, ensuring job security for employees and medical supply security for the region Sale MEDICLIN Johannesstift Diakonie Herzzentrum Coswig Medical Supply Security
BRIEF published on 02/23/2024 at 15:04, 9 months ago Sale of MEDICLIN Herzzentrum Coswig to Johannesstift Diakonie Sale MEDICLIN Johannesstift Diakonie Hospital Reform Medical Rehabilitation
PRESS RELEASE published on 09/21/2023 at 16:00, 1 year 2 months ago MediClin AG: Thomas Piefke becomes a member of MEDICLIN's Management Board and will be responsible for the post-acute segment in the future
PRESS RELEASE published on 07/31/2023 at 12:29, 1 year 3 months ago MediClin AG: Higher demand for medical, therapeutic and nursing services led to an increase in sales and earnings in the Group
PRESS RELEASE published on 06/16/2023 at 12:15, 1 year 5 months ago MediClin AG: MEDICLIN focusses on innovative outpatient concepts in rehabilitation
PRESS RELEASE published on 05/04/2023 at 12:51, 1 year 6 months ago MediClin AG: Encouraging development of Group sales in the first quarter of 2023
PRESS RELEASE published on 05/04/2023 at 09:00, 1 year 6 months ago MediClin AG: Mercurius Health acquires Robert Janker Klinik in Bonn, Germany, previously owned by MEDICLIN
PRESS RELEASE published on 03/31/2023 at 13:21, 1 year 7 months ago MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023
Published on 11/22/2024 at 23:55, 1 day 6 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 6 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 7 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 7 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 11 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 12 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 13 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 23 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 10 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 12 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 12 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
